Comments on: Monday Biotech Deal Review: November 23, 2009 http://crossborderbiotech.ca/2009/11/23/monday-canada-biotech-deal-review-november-23-2009/ Biotechnology, Health and Business in Canada, the United States and Worldwide Mon, 02 Apr 2012 12:31:04 +0000 hourly 1 http://wordpress.com/ By: Monday Biotech Deal Review: July 5, 2010 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/11/23/monday-canada-biotech-deal-review-november-23-2009/comment-page-1/#comment-1805 Mon, 05 Jul 2010 11:06:05 +0000 http://crossborderbiotech.ca/?p=3608#comment-1805 [...] Ondine Biopharma Corporation (TSX: OBP) intends to establish a subsidiary, “Sinuwave Technologies Corporation“, to develop and commercialize photodisinfection based products for the chronic sinusitis market. Sinuwave will licence Ondine technology, including technology obtained in Ondine’s acquistion of Advanced Photodynamic Technologies Inc. (covered here). [...]

]]> By: Monday Biotech Deal Review: February 15, 2010 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/11/23/monday-canada-biotech-deal-review-november-23-2009/comment-page-1/#comment-1399 Tue, 16 Feb 2010 21:03:44 +0000 http://crossborderbiotech.ca/?p=3608#comment-1399 [...] redeemed for proceeds to Nucryst shareholders of US$8,201,587.05.  The amalgamation follows the sale by Nucryst of substantially all of its assets in November 2009 to Smith & [...]

]]>